Cargando…
Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial
Objective. To investigate the safety and efficacy of MLC601 (NeuroAid) as a traditional Chinese medicine on motor recovery after ischemic stroke. Methods. This study was a double-blind, placebo-controlled clinical trial on 150 patients with a recent (less than 3 month) ischemic stroke. All patients...
Autores principales: | Harandi, A. A., Abolfazli, R., Hatemian, A., Ghragozlee, K., Ghaffar-Pour, M., Karimi, M., Shahbegi, S., Pakdaman, H., Tabasi, M., Tabatabae, A. L., Nourian, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138057/ https://www.ncbi.nlm.nih.gov/pubmed/21776364 http://dx.doi.org/10.4061/2011/721613 |
Ejemplares similares
-
Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study
por: Pakdaman, Hossein, et al.
Publicado: (2017) -
MLC601 in vascular dementia: an efficacy and safety pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2017) -
Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial
por: Pakdaman, Hossein, et al.
Publicado: (2015) -
Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study
por: Pakdaman, Hossein, et al.
Publicado: (2018) -
MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study
por: Pakdaman, Hossein, et al.
Publicado: (2023)